FDA Clarifies Information About Payment and Reimbursement to Research Subjects

FDA Clarifies Information About Payment and Reimbursement to Research Subjects

Today the Food and Drug Administration (FDA) published updates to the Payment for Research Subjects: Information Sheet to clarify that reimbursement for travel expenses to and from the clinical trial site and associated costs such as airfare, parking, and lodging are acceptable under current practices.  This update is in response to inquiries FDA received from stakeholders about appropriate reimbursement practices. The title of this information sheet has been revised to reflect these changes.  The new title is Payment and Reimbursement to Research Subjects.